HIMS & HERS HEALTH INC (HIMS) Stock Fundamental Analysis
NYSE:HIMS - New York Stock Exchange, Inc. - US4330001060 - Common Stock - Currency: USD
Taking everything into account, HIMS scores 6 out of 10 in our fundamental rating. HIMS was compared to 102 industry peers in the Health Care Providers & Services industry. While HIMS has a great health rating, its profitability is only average at the moment. HIMS is valued quite expensive, but it does show an excellent growth. These ratings would make HIMS suitable for growth investing!
1. Profitability
1.1 Basic Checks
HIMS had positive earnings in the past year.
In the past year HIMS had a positive cash flow from operations.
HIMS had negative earnings in 4 of the past 5 years.
In multiple years HIMS reported negative operating cash flow during the last 5 years.
1.2 Ratios
HIMS has a Return On Assets of 18.44%. This is amongst the best in the industry. HIMS outperforms 100.00% of its industry peers.
HIMS's Return On Equity of 29.93% is amongst the best of the industry. HIMS outperforms 95.10% of its industry peers.
Looking at the Return On Invested Capital, with a value of 14.93%, HIMS belongs to the top of the industry, outperforming 91.18% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.44% | ||
| ROE | 29.93% | ||
| ROIC | 14.93% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With an excellent Profit Margin value of 9.21%, HIMS belongs to the best of the industry, outperforming 94.12% of the companies in the same industry.
With a decent Operating Margin value of 6.48%, HIMS is doing good in the industry, outperforming 68.63% of the companies in the same industry.
With an excellent Gross Margin value of 77.04%, HIMS belongs to the best of the industry, outperforming 92.16% of the companies in the same industry.
HIMS's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.48% | ||
| PM (TTM) | 9.21% | ||
| GM | 77.04% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so HIMS is still creating some value.
HIMS has more shares outstanding than it did 1 year ago.
HIMS has more shares outstanding than it did 5 years ago.
There is no outstanding debt for HIMS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
An Altman-Z score of 26.34 indicates that HIMS is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 26.34, HIMS belongs to the best of the industry, outperforming 97.06% of the companies in the same industry.
HIMS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 26.34 |
ROIC/WACC1.64
WACC9.1%
2.3 Liquidity
HIMS has a Current Ratio of 1.59. This is a normal value and indicates that HIMS is financially healthy and should not expect problems in meeting its short term obligations.
HIMS has a Current ratio (1.59) which is in line with its industry peers.
A Quick Ratio of 1.32 indicates that HIMS should not have too much problems paying its short term obligations.
The Quick ratio of HIMS (1.32) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.59 | ||
| Quick Ratio | 1.32 |
3. Growth
3.1 Past
HIMS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 7000.00%, which is quite impressive.
Measured over the past years, HIMS shows a very strong growth in Earnings Per Share. The EPS has been growing by 60.35% on average per year.
The Revenue has grown by 85.99% in the past year. This is a very strong growth!
HIMS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 75.77% yearly.
EPS 1Y (TTM)7000%
EPS 3YN/A
EPS 5Y60.35%
EPS Q2Q%300%
Revenue 1Y (TTM)85.99%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%110.67%
3.2 Future
The Earnings Per Share is expected to grow by 41.75% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 27.61% on average over the next years. This is a very strong growth
EPS Next Y17.11%
EPS Next 2Y35.57%
EPS Next 3Y35.34%
EPS Next 5Y41.75%
Revenue Next Year60.2%
Revenue Next 2Y39.28%
Revenue Next 3Y33.27%
Revenue Next 5Y27.61%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
HIMS is valuated quite expensively with a Price/Earnings ratio of 88.71.
The rest of the industry has a similar Price/Earnings ratio as HIMS.
HIMS is valuated expensively when we compare the Price/Earnings ratio to 26.60, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 61.68, the valuation of HIMS can be described as expensive.
HIMS's Price/Forward Earnings ratio is in line with the industry average.
HIMS is valuated expensively when we compare the Price/Forward Earnings ratio to 22.43, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 88.71 | ||
| Fwd PE | 61.68 |
4.2 Price Multiples
62.75% of the companies in the same industry are cheaper than HIMS, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of HIMS is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 57.89 | ||
| EV/EBITDA | 96.56 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of HIMS may justify a higher PE ratio.
A more expensive valuation may be justified as HIMS's earnings are expected to grow with 35.34% in the coming years.
PEG (NY)5.18
PEG (5Y)1.47
EPS Next 2Y35.57%
EPS Next 3Y35.34%
5. Dividend
5.1 Amount
HIMS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
61.21
-1.13 (-1.81%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners79.43%
Inst Owner Change-2.77%
Ins Owners11.03%
Ins Owner Change9.19%
Market Cap13.69B
Analysts68.57
Price Target43.48 (-28.97%)
Short Float %32.85%
Short Ratio1.83
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)33.39%
Min EPS beat(2)4.62%
Max EPS beat(2)62.17%
EPS beat(4)4
Avg EPS beat(4)192.83%
Min EPS beat(4)4.62%
Max EPS beat(4)666.87%
EPS beat(8)7
Avg EPS beat(8)156.65%
EPS beat(12)11
Avg EPS beat(12)110.67%
EPS beat(16)12
Avg EPS beat(16)78.36%
Revenue beat(2)2
Avg Revenue beat(2)3.52%
Min Revenue beat(2)0.3%
Max Revenue beat(2)6.75%
Revenue beat(4)4
Avg Revenue beat(4)3.3%
Min Revenue beat(4)0.3%
Max Revenue beat(4)6.75%
Revenue beat(8)6
Avg Revenue beat(8)1.56%
Revenue beat(12)10
Avg Revenue beat(12)2.89%
Revenue beat(16)14
Avg Revenue beat(16)3.76%
PT rev (1m)-2.9%
PT rev (3m)50.98%
EPS NQ rev (1m)-3.66%
EPS NQ rev (3m)-0.86%
EPS NY rev (1m)1%
EPS NY rev (3m)22.77%
Revenue NQ rev (1m)-3.04%
Revenue NQ rev (3m)5.94%
Revenue NY rev (1m)1.83%
Revenue NY rev (3m)14.16%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 88.71 | ||
| Fwd PE | 61.68 | ||
| P/S | 7.67 | ||
| P/FCF | 57.89 | ||
| P/OCF | 40.95 | ||
| P/B | 24.93 | ||
| P/tB | 35.28 | ||
| EV/EBITDA | 96.56 |
EPS(TTM)0.69
EY1.13%
EPS(NY)0.99
Fwd EY1.62%
FCF(TTM)1.06
FCFY1.73%
OCF(TTM)1.49
OCFY2.44%
SpS7.98
BVpS2.46
TBVpS1.74
PEG (NY)5.18
PEG (5Y)1.47
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.44% | ||
| ROE | 29.93% | ||
| ROCE | 18.9% | ||
| ROIC | 14.93% | ||
| ROICexc | 31.63% | ||
| ROICexgc | 71.61% | ||
| OM | 6.48% | ||
| PM (TTM) | 9.21% | ||
| GM | 77.04% | ||
| FCFM | 13.25% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
F-Score6
Asset Turnover2
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 437.46% | ||
| Cap/Sales | 5.48% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 242.39% | ||
| Profit Quality | 143.86% | ||
| Current Ratio | 1.59 | ||
| Quick Ratio | 1.32 | ||
| Altman-Z | 26.34 |
F-Score6
WACC9.1%
ROIC/WACC1.64
Cap/Depr(3y)228.03%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.66%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)7000%
EPS 3YN/A
EPS 5Y60.35%
EPS Q2Q%300%
EPS Next Y17.11%
EPS Next 2Y35.57%
EPS Next 3Y35.34%
EPS Next 5Y41.75%
Revenue 1Y (TTM)85.99%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%110.67%
Revenue Next Year60.2%
Revenue Next 2Y39.28%
Revenue Next 3Y33.27%
Revenue Next 5Y27.61%
EBIT growth 1Y2214.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year315.19%
EBIT Next 3Y91.04%
EBIT Next 5Y64.69%
FCF growth 1Y3973.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y14096.9%
OCF growth 3YN/A
OCF growth 5YN/A